NP47923c Eculizumab
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-040dc332014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
3
1 SME
Lots
1
1 awarded
Published
07 Feb 2024
Description
Supply of eculizumab to NHS Scotland.
Scope
- Reference
- ocds-h6vhtk-040dc3
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| API Sources | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded suppliers· 3 suppliers
Awarded —
Award value
—
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Amgen Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Ustekinumab | contract | — | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| Transitional Drugs 6 | contract | — | 30 Mar 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | contract | — | 04 Dec 2025 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |
| Romiplostim (Nplate®) | contract | — | 10 Sept 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |